Attached files
| file | filename |
|---|---|
| S-1 - SAFECODE DRUG TECHNOLOGIES CORP. | v221470_s1.htm |
| EX-3.2 - SAFECODE DRUG TECHNOLOGIES CORP. | v221470_ex3-2.htm |
| EX-3.1 - SAFECODE DRUG TECHNOLOGIES CORP. | v221470_ex3-1.htm |
| EX-3.3 - SAFECODE DRUG TECHNOLOGIES CORP. | v221470_ex3-3.htm |
| EX-5.1 - SAFECODE DRUG TECHNOLOGIES CORP. | v221470_ex5-1.htm |
| EX-99.1 - SAFECODE DRUG TECHNOLOGIES CORP. | v221470_ex99-1.htm |
| EX-10.1 - SAFECODE DRUG TECHNOLOGIES CORP. | v221470_ex10-1.htm |
Weinberg & Baer LLC
115 Sudbrook Lane, Baltimore, MD 21208
Phone (410) 702-5660
Mr. Joel Klopfer, President
SafeCode Drug Technologies Corp.
6 Meever HaMitlah Street
Jerusalem 97761, Israel
Dear Mr. Klopfer:
CONSENT OF INDEPENDENT AUDITOR
We consent to the incorporation in the Registration Statement of SafeCode Drug Technologies Corp. on Form S-1 of our report on the financial statements of the Company as its registered independent auditor dated January 23, 2011, as of and for the period ended December 31, 2010. We further consent to the reference to our firm in the section on Experts.
Respectfully submitted,
Weinberg & Baer LLC
Baltimore, Maryland
May 13, 2011